INNOVADERM CRO IS NOW INDERO.
circle

Atopic Dermatitis (AD) Rescue Case Study

Indero

Indero

Team of Experts

Click here for a PDF version of this case study

Outcomes

Indero successfully rescued this AD study and this resulted in:

215% enrollment increase in half the time.​

Dramatic improvement of sites’ engagement.

 

Study Characteristics

  • Study Phase: IIa
  • Patient Population: Atopic Dermatitis
  • IP Route of Administration: Systemic
  • Initial Sites Distribution: 27 in 1 country (US)​
  • Post Rescue Final Sites Distribution: ​30 (kept 15 from the original selection) in 2 continents (Europe and North America)

 

Study Challenges and Solutions

Challenges #1

Patient Recruitment Concerns & Poor Site Management:

  • Enrollment struggles led to trial delays
  • Significant site payment delays and lack of site support and training

Solutions

  • Enhanced outreach and strategic partnerships with additional sites and patients advocacy groups boosted enrollment
  • Manual work done to accelerate payment processes and satisfy sites’ needs

Outcome

  • Recruitment Triumph – Achieved 215% increase in half the time
  • Sites relation – Dramatic improvement with Indero takeover, re-engaging disengaged sites

Challenge #2

Data Oversight Issues:

Significant 6-month data cleaning backlog potentially causing data inaccuracies

Solution

Achieved through rigorous and extensive monitoring, ensuring unparalleled quality

Challenge #3

Missed Deadlines:

Operational inefficiencies derailed the schedule

Solution

Comprehensive restructuration became the trial’s saving grace to improve coordination and adherence to timelines

 

Need help with your next dermatology or rheumatology study? Tell us a little about your needs.

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Is Now

We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Additionally, our Clinical Research Unit (CRU) will keep the name Innovaderm and will continue to conduct dermatology studies.

Site Selection & Management

Our long-standing relationships with key opinion leaders and highly performing sites result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on the competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.

Hands, tablet and contact us with healthcare marketing or advertising on a website in the medical industry.

Patient Recruitment

Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including the site selection process, budget and contract negotiations, patient engagement, and recruitment enrollment projections, all while respecting your study timelines.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including the site selection process, budget and contract negotiations, patient engagement, and recruitment enrollment projections, all while respecting your study timelines.